Abstract
Infective endocarditis (IE) is an uncommon infection, occurring as a complication in varying percentages of bacteremic episodes. The ability of an organism to cause endocarditis is the result of an interplay between the predisposing structural abnormalities of the cardiac valve for bacterial adherence, the adhesion of circulating bacteria to the valvular surface, and the ability of the adherent bacteria to survive on the surface and propagate as vegetation or systemic emboli. Certain bacteria, if present in the bloodstream, may colonize the initially sterile vegetation composed of fibrin and platelets; bacterial growth enlarges the vegetation, further impeding blood flow and inciting inflammation that involves the vegetation and adjacent endothelium. The true incidence of endocarditis complicating each of the bacterial species causing IE is difficult to estimate. About 20 %–30 % of individuals with community-acquired staphylococcal bacteremia develop IE [1, 2].
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Chang FY et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82(5):322–32.
Fowler Jr VG et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163(17):2066–72.
Garrison PK, Freedman LR. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med. 1970;42(6):394–410.
Durack DT. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol. 1975;115(2):81–9.
O'Brien L et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol. 2002;44(4):1033–44.
McNicol A, Israels SJ. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharmacol. 2010;88(5):510–24.
Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006;4(6):445–57.
Freedman LR, Valone Jr J. Experimental infective endocarditis. Prog Cardiovasc Dis. 1979;22(3):169–80.
Gould K et al. Adherence of bacteria to heart valves in vitro. J Clin Invest. 1975;56(6):1364–70.
Didierlaurent A, Goulding J, Hussell T. The impact of successive infections on the lung microenvironment. Immunology. 2007;122(4):457–65.
Scheld WM, Valone JA, Sande MA. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest. 1978;61(5):1394–404.
Edwards AM et al. Staphylococcus aureus extracellular adherence protein triggers TNFalpha release, promoting attachment to endothelial cells via protein A. PLoS One. 2012;7(8):e43046.
Bayer AS et al. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun. 1997;65(11):4652–60.
•• Schubert S et al. Staphylococcus aureus alpha-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins (Basel). 2011;3(2):120–33. An important study illustrating the effect of staphylococcal alpha toxin on immediate and prolonged platelet activation, which could be decreased by targeting mTOR.
•• Yamaguchi T, Soutome S, Oho T. Identification and characterization of a fibronectin-binding protein from Granulicatella adiacens. Mol Oral Microbiol. 2011;26(6):353–64. Identification of a surface protein, designated Cha, which binds to fibronectin and is involved in adherence to fibronectin. May provide potential therapeutic target.
Yeaman MR et al. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis. 1992;166(1):65–73.
Josefsson E et al. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology. 1998;144(12):3387–95.
Kuypers JM, Proctor RA. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun. 1989;57(8):2306–12.
Moreillon P et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63(12):4738–43.
• Veloso TR et al. Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infect Immun. 2013;81(3):697–703. Important study hgihlighting the role of bacterial adhesins in initiation and subsequent prpogation of endocariditis lesion.
Yeh CY, Chen JY, Chia JS. Glucosyltransferases of viridans group streptococci modulate interleukin-6 and adhesion molecule expression in endothelial cells and augment monocytic cell adherence. Infect Immun. 2006;74(2):1273–83.
McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82(4):681–8.
Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368(15):1425–33.
Weinberger I et al. Native valve infective endocarditis in the 1970s versus the 1980s: underlying cardiac lesions and infecting organisms. Clin Cardiol. 1990;13(2):94–8.
Lepeschkin E. On the relation between the site of valvular involvement in endocarditis and the blood pressure resting on the valve. Am J Med Sci. 1952;224(3):318–9.
Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J. 1995;16(Suppl B):2–6.
Bansal RC. Infective endocarditis. Med Clin North Am. 1995;79(5):1205–40.
Millaire A et al. Obstruction of the left main coronary ostium due to an aortic vegetation: survival after early surgery. Clin Infect Dis. 1996;22(1):192–3.
Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17(3):313–20. quiz 321-2.
Rodbard S. Blood velocity and endocarditis. Circulation. 1963;27:18–28.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Yoav Keynan declares that he has no conflict of interest.
Ethan Rubinstein declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keynan, Y., Rubinstein, E. Pathophysiology of Infective Endocarditis. Curr Infect Dis Rep 15, 342–346 (2013). https://doi.org/10.1007/s11908-013-0346-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-013-0346-0